NY AG Says Doryx Dismissal Doesn't Doom Namenda Case

New York's attorney general has told the Second Circuit the recent dismissal of a product-hopping suit in Pennsylvania over acne drug Doryx had little bearing on the state's own antitrust suit...

Already a subscriber? Click here to view full article